Validation of an NGS mutation detection panel for melanoma

BACKGROUND: Knowledge of the genotype of melanoma is important to guide patient management. Identification of mutations in BRAF and c-KIT lead directly to targeted treatment, but it is also helpful to know if there are driver oncogene mutations in NRAS, GNAQ or GNA11 as these patients may benefit fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Reiman, Anne, Kikuchi, Hugh, Scocchia, Daniela, Smith, Peter, Tsang, Yee Wah, Snead, David, Cree, Ian A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322598/
https://www.ncbi.nlm.nih.gov/pubmed/28228113
http://dx.doi.org/10.1186/s12885-017-3149-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322598/
https://www.ncbi.nlm.nih.gov/pubmed/28228113
http://dx.doi.org/10.1186/s12885-017-3149-0

Ejemplares similares